Bain & Company’s recently released seventh Global Technology Report has handed the global artificial intelligence industry an invoice, and seventy per cent of it can only be paid with products nobody has built yet.
According to the report, the industry must earn $6 trillion in annual revenue by 2031 to justify the capital going into data centres, and that existing consumer and enterprise AI services may generate as much as $1.8 trillion of that, leaving $4.2 trillion of new revenue to be created.
It’s important to mention that everything the technology sells today, from chatbots to workplace copilots, covers less than a third of the projected sum.
Bain expects the shortfall to come from nascent segments, from autonomous machines and robotics to drug discovery, mental health and energy generation. These are sectors that are small, heavily regulated or still confined to laboratories, and the industry is counting on them to produce trillions within five years.
David Crawford, the report’s lead author, concedes the scale of the ask. He says the industry needs a wave of innovation bigger than anything mobile and cloud unlocked, and that funding the build sustainably would require adding roughly 1% to the annual global GDP growth rate.
Realistically speaking, economies rarely accelerate on that scale just because an industry needs them to.
This is not Bain’s first attempt at the sum. Last September it estimated that artificial intelligence companies would need $2 trillion in annual revenue by 2030 and predicted their revenue would fall $800 billion short. The new target is three times larger and arrives a year later. The two reports may define their scope differently, but the direction is clear enough: the cost of the build-out is rising faster than the evidence that anyone will pay for it.
The cost side is stark. The report projects $5 trillion to $6.5 trillion of data-centre spending by 2030, adding at least 150 gigawatts of capacity. Data-centre sizes and costs are doubling roughly every 12 to 16 months, in part because chip prices keep surging. Financing can be arranged, but transformers, water and grid connections cannot be conjured on the same timetable. Shortages of all three, along with fierce local opposition, blocked or delayed $68 billion worth of US projects in the June quarter.
The $6 trillion AI revenue call is uniform
Other analysts have added their voices to the call. Goldman Sachs this week put the break-even for the five biggest US hyperscalers at roughly $300 billion in annual AI revenue, set against $800 billion of infrastructure spending in 2026, with AI cloud revenue running about $70 billion above its pre-AI trend and leaving a gap of roughly $230 billion a year.
Goldman’s yardstick is narrower than Bain’s, covering only the hyperscalers and only this year’s build, yet it points the same way. Sequoia’s David Cahn calculated a gap of about $600 billion a year, and Allianz Research puts the divergence between AI capex and revenue growth at around 46%, above the 32% recorded during the 2001 telecoms excess.
Meanwhile, every dollar of hyperscaler capex is artificial intelligence spending, and Goldman itself warns of double-counting risk and assumes that nearly all capex above 2022 levels is AI-related. Bain’s figure is also a hurdle rate rather than a forecast, so it tells us what must happen, not what will.
Yet, the more troubling point is that no hyperscaler is likely to cut spending unilaterally and cede ground to rivals, which makes the capex cycle self-reinforcing whatever the near-term returns. A race in which stopping is unaffordable is exactly where poor returns pile up unnoticed, because the spending decision no longer depends on the returns.
Bain has converted a mood into a measurable test. Whether AI is useful stopped being the question some time ago. The question now is whether that usefulness can be priced at a scale beyond the smartphone economy, in markets that barely exist, before the power grid and the bond market run out of patience.
Two things will show how it is going through 2027. One is whether robotics and drug discovery start reporting real revenue lines. The other is whether capex guidance keeps climbing without them. If the second happens without the first, the industry is no longer investing in a proven market and is simply betting that one will appear.
Technext Newsletter
Get the best of Africa’s daily tech to your inbox – first thing every morning.
Join the community now!
